The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Animal Stem Cell Therapy Market Research Report 2024
Synopsis
Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.
The global Animal Stem Cell Therapy market was valued at US$ 203.8 million in 2023 and is anticipated to reach US$ 482.9 million by 2030, witnessing a CAGR of 12.8% during the forecast period 2024-2030.
Global 5 largest manufacturers of Animal Stem Cell Therapy are Ardent Animal Health, VetStem, Medrego, Animal General and Magellan Stem Cells, which make up over 17%. Among them, Ardent Animal Health is the leader with about 6% market share.
Asia Pacific is the largest market, with a share about 50%, followed by North America and Europe, with the share about 26% and 24%. In terms of product type, Dogs Stem Cell Therapy occupies the largest share of the total market, about 47%. And in terms of application, the largest application is Veterinary Hospitals, followed by Research Organizations.
This report aims to provide a comprehensive presentation of the global market for Animal Stem Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Stem Cell Therapy.
Report Scope
The Animal Stem Cell Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Animal Stem Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Animal Stem Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ardent Animal Health
VetStem
Medrego
Vetbiologics
Vetherapy
Celavet
Magellan Stem Cells
Animal General
Stem Care Company
Animal Cell Therapies
Cell Therapy Sciences
Animacel
Segment by Type
Dogs Stem Cell Therapy
Horses Stem Cell Therapy
Others
Segment by Application
Veterinary Hospitals
Research Organizations
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Animal Stem Cell Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.
The global Animal Stem Cell Therapy market was valued at US$ 203.8 million in 2023 and is anticipated to reach US$ 482.9 million by 2030, witnessing a CAGR of 12.8% during the forecast period 2024-2030.
Global 5 largest manufacturers of Animal Stem Cell Therapy are Ardent Animal Health, VetStem, Medrego, Animal General and Magellan Stem Cells, which make up over 17%. Among them, Ardent Animal Health is the leader with about 6% market share.
Asia Pacific is the largest market, with a share about 50%, followed by North America and Europe, with the share about 26% and 24%. In terms of product type, Dogs Stem Cell Therapy occupies the largest share of the total market, about 47%. And in terms of application, the largest application is Veterinary Hospitals, followed by Research Organizations.
This report aims to provide a comprehensive presentation of the global market for Animal Stem Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Stem Cell Therapy.
Report Scope
The Animal Stem Cell Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Animal Stem Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Animal Stem Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ardent Animal Health
VetStem
Medrego
Vetbiologics
Vetherapy
Celavet
Magellan Stem Cells
Animal General
Stem Care Company
Animal Cell Therapies
Cell Therapy Sciences
Animacel
Segment by Type
Dogs Stem Cell Therapy
Horses Stem Cell Therapy
Others
Segment by Application
Veterinary Hospitals
Research Organizations
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Animal Stem Cell Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Animal Stem Cell Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Dogs Stem Cell Therapy
1.2.3 Horses Stem Cell Therapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Animal Stem Cell Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Veterinary Hospitals
1.3.3 Research Organizations
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Animal Stem Cell Therapy Market Perspective (2019-2030)
2.2 Animal Stem Cell Therapy Growth Trends by Region
2.2.1 Global Animal Stem Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Animal Stem Cell Therapy Historic Market Size by Region (2019-2024)
2.2.3 Animal Stem Cell Therapy Forecasted Market Size by Region (2025-2030)
2.3 Animal Stem Cell Therapy Market Dynamics
2.3.1 Animal Stem Cell Therapy Industry Trends
2.3.2 Animal Stem Cell Therapy Market Drivers
2.3.3 Animal Stem Cell Therapy Market Challenges
2.3.4 Animal Stem Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Animal Stem Cell Therapy Players by Revenue
3.1.1 Global Top Animal Stem Cell Therapy Players by Revenue (2019-2024)
3.1.2 Global Animal Stem Cell Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Animal Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Animal Stem Cell Therapy Revenue
3.4 Global Animal Stem Cell Therapy Market Concentration Ratio
3.4.1 Global Animal Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Animal Stem Cell Therapy Revenue in 2023
3.5 Animal Stem Cell Therapy Key Players Head office and Area Served
3.6 Key Players Animal Stem Cell Therapy Product Solution and Service
3.7 Date of Enter into Animal Stem Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Animal Stem Cell Therapy Breakdown Data by Type
4.1 Global Animal Stem Cell Therapy Historic Market Size by Type (2019-2024)
4.2 Global Animal Stem Cell Therapy Forecasted Market Size by Type (2025-2030)
5 Animal Stem Cell Therapy Breakdown Data by Application
5.1 Global Animal Stem Cell Therapy Historic Market Size by Application (2019-2024)
5.2 Global Animal Stem Cell Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Animal Stem Cell Therapy Market Size (2019-2030)
6.2 North America Animal Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Animal Stem Cell Therapy Market Size by Country (2019-2024)
6.4 North America Animal Stem Cell Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Animal Stem Cell Therapy Market Size (2019-2030)
7.2 Europe Animal Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Animal Stem Cell Therapy Market Size by Country (2019-2024)
7.4 Europe Animal Stem Cell Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Animal Stem Cell Therapy Market Size (2019-2030)
8.2 Asia-Pacific Animal Stem Cell Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Animal Stem Cell Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Animal Stem Cell Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Animal Stem Cell Therapy Market Size (2019-2030)
9.2 Latin America Animal Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Animal Stem Cell Therapy Market Size by Country (2019-2024)
9.4 Latin America Animal Stem Cell Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Animal Stem Cell Therapy Market Size (2019-2030)
10.2 Middle East & Africa Animal Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Animal Stem Cell Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Animal Stem Cell Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ardent Animal Health
11.1.1 Ardent Animal Health Company Detail
11.1.2 Ardent Animal Health Business Overview
11.1.3 Ardent Animal Health Animal Stem Cell Therapy Introduction
11.1.4 Ardent Animal Health Revenue in Animal Stem Cell Therapy Business (2019-2024)
11.1.5 Ardent Animal Health Recent Development
11.2 VetStem
11.2.1 VetStem Company Detail
11.2.2 VetStem Business Overview
11.2.3 VetStem Animal Stem Cell Therapy Introduction
11.2.4 VetStem Revenue in Animal Stem Cell Therapy Business (2019-2024)
11.2.5 VetStem Recent Development
11.3 Medrego
11.3.1 Medrego Company Detail
11.3.2 Medrego Business Overview
11.3.3 Medrego Animal Stem Cell Therapy Introduction
11.3.4 Medrego Revenue in Animal Stem Cell Therapy Business (2019-2024)
11.3.5 Medrego Recent Development
11.4 Vetbiologics
11.4.1 Vetbiologics Company Detail
11.4.2 Vetbiologics Business Overview
11.4.3 Vetbiologics Animal Stem Cell Therapy Introduction
11.4.4 Vetbiologics Revenue in Animal Stem Cell Therapy Business (2019-2024)
11.4.5 Vetbiologics Recent Development
11.5 Vetherapy
11.5.1 Vetherapy Company Detail
11.5.2 Vetherapy Business Overview
11.5.3 Vetherapy Animal Stem Cell Therapy Introduction
11.5.4 Vetherapy Revenue in Animal Stem Cell Therapy Business (2019-2024)
11.5.5 Vetherapy Recent Development
11.6 Celavet
11.6.1 Celavet Company Detail
11.6.2 Celavet Business Overview
11.6.3 Celavet Animal Stem Cell Therapy Introduction
11.6.4 Celavet Revenue in Animal Stem Cell Therapy Business (2019-2024)
11.6.5 Celavet Recent Development
11.7 Magellan Stem Cells
11.7.1 Magellan Stem Cells Company Detail
11.7.2 Magellan Stem Cells Business Overview
11.7.3 Magellan Stem Cells Animal Stem Cell Therapy Introduction
11.7.4 Magellan Stem Cells Revenue in Animal Stem Cell Therapy Business (2019-2024)
11.7.5 Magellan Stem Cells Recent Development
11.8 Animal General
11.8.1 Animal General Company Detail
11.8.2 Animal General Business Overview
11.8.3 Animal General Animal Stem Cell Therapy Introduction
11.8.4 Animal General Revenue in Animal Stem Cell Therapy Business (2019-2024)
11.8.5 Animal General Recent Development
11.9 Stem Care Company
11.9.1 Stem Care Company Company Detail
11.9.2 Stem Care Company Business Overview
11.9.3 Stem Care Company Animal Stem Cell Therapy Introduction
11.9.4 Stem Care Company Revenue in Animal Stem Cell Therapy Business (2019-2024)
11.9.5 Stem Care Company Recent Development
11.10 Animal Cell Therapies
11.10.1 Animal Cell Therapies Company Detail
11.10.2 Animal Cell Therapies Business Overview
11.10.3 Animal Cell Therapies Animal Stem Cell Therapy Introduction
11.10.4 Animal Cell Therapies Revenue in Animal Stem Cell Therapy Business (2019-2024)
11.10.5 Animal Cell Therapies Recent Development
11.11 Cell Therapy Sciences
11.11.1 Cell Therapy Sciences Company Detail
11.11.2 Cell Therapy Sciences Business Overview
11.11.3 Cell Therapy Sciences Animal Stem Cell Therapy Introduction
11.11.4 Cell Therapy Sciences Revenue in Animal Stem Cell Therapy Business (2019-2024)
11.11.5 Cell Therapy Sciences Recent Development
11.12 Animacel
11.12.1 Animacel Company Detail
11.12.2 Animacel Business Overview
11.12.3 Animacel Animal Stem Cell Therapy Introduction
11.12.4 Animacel Revenue in Animal Stem Cell Therapy Business (2019-2024)
11.12.5 Animacel Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
